Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical FY Profit Attributable RMB185.4 Mln

Tianjin Development Holdings

28/02/2019 06:57

Feb 28 (Reuters) - Tianjin Development Holdings Ltd
 0882.HK :
    * TIANJIN LISHENG PHARMACEUTICAL FY NET PROFIT ATTRIBUTABLE
RMB185.4 MILLION VERSUS RMB116.8 MILLION
    * TIANJIN LISHENG PHARMACEUTICAL CO.'S FY TOTAL REVENUE FROM
OPERATIONS RMB1.50 BILLION VERSUS RMB1.03 BILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKSc1Q7HH
Further company coverage:  0882.HK 

 ((Reuters.Briefs@thomsonreuters.com;))